This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2026 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.70% per year. These returns cover a period from January 1, 1988 through April 6, 2026. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View the Zacks #1 Rank List
medical-devices: Archive
PacBio Pre-Q1 Analysis: Time to Buy, Hold or Sell the Stock Now?
by Zacks Equity Research
PACB heads into Q1 earnings with strong consumables momentum, but muted academic demand and macro pressures cloud near-term visibility.
ILMNNegative Net Change PACBNegative Net Change TXGNegative Net Change
medical medical-devices
RVTY Q1 Earnings Beat Estimates on Organic Growth & Strong Execution
by Zacks Equity Research
Revvity beat Q1 EPS and revenue estimates as 3% organic growth and portfolio execution offset margin pressure and China ImmunoDx divest plans.
ISRGNegative Net Change CAHPositive Net Change WSTPositive Net Change RVTYNegative Net Change
earnings medical medical-devices
Cencora to Report Q2 Earnings: What's in Store for the Stock?
by Zacks Equity Research
COR heads into Q2 earnings with expected steady specialty-driven growth, but customer losses and pricing pressures could temper results.
HSICPositive Net Change IDXXNegative Net Change CORNegative Net Change MBOTNo Net Change
medical medical-devices
After Golden Cross, Penguin Solutions, Inc. (PENG)'s Technical Outlook is Bright
by Zacks Equity Research
Should investors be excited or worried when a stock's 50-day simple moving average crosses above the 200-day simple moving average?
PENGNegative Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
HSIC Q1 Earnings & Revenues Surpass Estimates, Gross Margin Rises
by Zacks Equity Research
Henry Schein tops Q1 estimates with 14.8% EPS growth and rising margins, as strong segment performance and market share gains drive solid revenue expansion.
LHNegative Net Change ISRGNegative Net Change HSICPositive Net Change BTSGNegative Net Change
earnings medical medical-devices
Zacks Industry Outlook Highlights Veeva Systems, Doximity and Omnicell
by Zacks Equity Research
Veeva Systems, Doximity and Omnicell ride rising AI-driven healthcare demand as medical info systems expand despite cybersecurity and regulatory risks.
OMCLNegative Net Change VEEVPositive Net Change DOCSPositive Net Change
medical-devices
Can Sustained Product Momentum Drive BDX Stock Before Q2 Earnings?
by Zacks Equity Research
BD rides on Medical and Interventional product momentum, but China dynamics and research funding could weigh on second-quarter fiscal 2026 results.
BDXNegative Net Change MCKPositive Net Change HSICPositive Net Change COONegative Net Change
earnings medical medical-devices
Solventum to Post Q1 Earnings: Is a Beat Likely for the Stock?
by Zacks Equity Research
SOLV gears up for Q1 earnings with modest growth expected, margin pressure looming and cost initiatives plus MedSurg momentum shaping results outlook.
HSICPositive Net Change IDXXNegative Net Change MBOTNo Net Change SOLVNegative Net Change
medical medical-devices
DENTSPLY SIRONA to Post Q1 Earnings: What's in Store for the Stock?
by Zacks Equity Research
XRAY heads into Q1 earnings with U.S. softness, tariff pressure and transformation costs weighing on margins as investors watch for signs of stabilization.
XRAYNegative Net Change HSICPositive Net Change IDXXNegative Net Change MBOTNo Net Change
medical medical-devices
3 Medical Info Systems Stocks Riding the GenAI Wave in a Tough Market
by Urmimala Biswas
Doximity, Veeva and Omnicell ride surging GenAI adoption in healthcare, tapping digital demand despite market pressure and rising cybersecurity risks.
VEEVPositive Net Change OMCLNegative Net Change DOCSPositive Net Change
artificial-intelligence hospitals medical-devices robotics tech-stocks